Optimal dose of buprenorphine in opioid use disorder treatment: a review of pharmacodynamic and efficacy data
出版年份 2020 全文链接
标题
Optimal dose of buprenorphine in opioid use disorder treatment: a review of pharmacodynamic and efficacy data
作者
关键词
-
出版物
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
Volume 46, Issue 1, Pages 1-7
出版商
Informa UK Limited
发表日期
2020-01-09
DOI
10.1080/03639045.2019.1706552
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The importance of buprenorphine research in the opioid crisis
- (2019) Sarah A. Pendergrass et al. MOLECULAR PSYCHIATRY
- Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Barbara R Haight et al. LANCET
- Management of opioid use disorder in the USA: present status and future directions
- (2019) Carlos Blanco et al. LANCET
- Predictors of craving and substance use among patients with alcohol, tobacco, cannabis or opiate addictions: Commonalities and specificities across substances
- (2018) Fuschia Serre et al. ADDICTIVE BEHAVIORS
- A cluster-analytic profiling of heroin-dependent patients based on level, clinical adequacy, and patient-desired adjustment of buprenorphine dosage during buprenorphine-naloxone maintenance treatment in sixteen Spanish centers
- (2018) Saul Alcaraz et al. DRUG AND ALCOHOL DEPENDENCE
- Evidence of validity and reliability of the Opiate Dosage Adequacy Scale (ODAS) in a sample of heroin addicted patients in buprenorphine/naloxone maintenance treatment
- (2018) Francisco González-Saiz et al. DRUG AND ALCOHOL DEPENDENCE
- Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial
- (2018) Joshua D Lee et al. LANCET
- Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis
- (2018) Jun Ma et al. MOLECULAR PSYCHIATRY
- Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder
- (2018) Michelle R. Lofwall et al. JAMA Internal Medicine
- Buprenorphine Pharmacology Review
- (2018) Marion A. Coe et al. Journal of Addiction Medicine
- Safety of a Rapidly Dissolving Buprenorphine/Naloxone Sublingual Tablet (BNX-RDT) for Treatment of Opioid Dependence
- (2017) Kent Hoffman et al. Journal of Addiction Medicine
- Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder
- (2017) Sharon L. Walsh et al. JAMA Psychiatry
- A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activities
- (2016) Dan Lu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder
- (2016) Azmi F. Nasser et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Effects of a Higher-bioavailability Buprenorphine/Naloxone Sublingual Tablet Versus Buprenorphine/Naloxone Film for the Treatment of Opioid Dependence During Induction and Stabilization: A Multicenter, Randomized Trial
- (2015) Erik W. Gunderson et al. CLINICAL THERAPEUTICS
- Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: Implications for clinical use and policy
- (2014) Mark K. Greenwald et al. DRUG AND ALCOHOL DEPENDENCE
- Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone
- (2013) Richard N. Rosenthal et al. ADDICTION
- Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
- (2013) Yih-Ing Hser et al. ADDICTION
- Safety, Effectiveness and Tolerance of Buprenorphine-Naloxone in the Treatment of Opioid Dependence: Results from a Nationwide Non-Interventional Study in Routine Care
- (2013) S. Apelt et al. PHARMACOPSYCHIATRY
- A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans
- (2012) Shannon Gwin Mitchell et al. DRUG AND ALCOHOL DEPENDENCE
- Multi-centre observational study of buprenorphine use in 32 Italian drug addiction centres
- (2008) C. Leonardi et al. DRUG AND ALCOHOL DEPENDENCE
- Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study
- (2008) Michael Soyka et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More